Conflicts of interest
Corina J.G. van den Hurk: IKNL received research funding from for-profit health care company AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Ipsen and Merck. All other authors have no conflicts of interest. The rest of the SYMPRO-Lung Consortium has nothing to declare.